Phase 3 Study to Assess the Long-Term Safety and Efficacy of JTZ-951 in Anemic Patients with Chronic Kidney Disease Not Requiring Dialysis <Long-Term Study> (SYMPHONY ND-Long)
Latest Information Update: 11 Jan 2022
At a glance
- Drugs Enarodustat (Primary)
- Indications Anaemia
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Japan Tobacco
- 07 Nov 2017 New trial record